nasdaq:acad
|
https://www.indeed.com/cmp/acadia-pharmaceuticals
|
Aug 29th, 2022 12:00AM
|
Open
|
ACADIA Pharmaceuticals
|
|
Healthcare
|
ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase IV development as a treatment for Parkinson's disease psychosis.
|
RRv1_5M_25M
|
San Diego, CA
|
|
|
|
3.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18.00
|
18.00
|
3.50
|
3.90
|
3.20
|
3.40
|
3.60
|
8.00
|
About a week
|
9.00
|
MEDIUM
|
8.00
|
FAVORABLE
|
|
|
|
Aug 29th, 2022 11:16AM
|
Aug 29th, 2022 11:16AM
|
ACADIA Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:acad
|
https://www.indeed.com/cmp/acadia-pharmaceuticals
|
Aug 28th, 2022 12:00AM
|
Open
|
ACADIA Pharmaceuticals
|
|
Healthcare
|
ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase IV development as a treatment for Parkinson's disease psychosis.
|
RRv1_5M_25M
|
San Diego, CA
|
|
|
|
3.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18.00
|
18.00
|
3.50
|
3.90
|
3.20
|
3.40
|
3.60
|
8.00
|
About a week
|
9.00
|
MEDIUM
|
8.00
|
FAVORABLE
|
|
|
|
Aug 28th, 2022 04:15AM
|
Aug 28th, 2022 04:15AM
|
ACADIA Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:acad
|
https://www.indeed.com/cmp/acadia-pharmaceuticals
|
Aug 27th, 2022 12:00AM
|
Open
|
ACADIA Pharmaceuticals
|
|
Healthcare
|
ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase IV development as a treatment for Parkinson's disease psychosis.
|
RRv1_5M_25M
|
San Diego, CA
|
|
|
|
3.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18.00
|
18.00
|
3.50
|
3.90
|
3.20
|
3.40
|
3.60
|
8.00
|
About a week
|
9.00
|
MEDIUM
|
8.00
|
FAVORABLE
|
|
|
|
Aug 27th, 2022 03:35AM
|
Aug 27th, 2022 03:35AM
|
ACADIA Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:acad
|
https://www.indeed.com/cmp/acadia-pharmaceuticals
|
Aug 25th, 2022 12:00AM
|
Open
|
ACADIA Pharmaceuticals
|
|
Healthcare
|
ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase IV development as a treatment for Parkinson's disease psychosis.
|
RRv1_5M_25M
|
San Diego, CA
|
|
|
|
3.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18.00
|
18.00
|
3.50
|
3.90
|
3.20
|
3.40
|
3.60
|
8.00
|
About a week
|
9.00
|
MEDIUM
|
8.00
|
FAVORABLE
|
|
|
|
Aug 25th, 2022 08:15AM
|
Aug 25th, 2022 08:15AM
|
ACADIA Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:acad
|
https://www.indeed.com/cmp/acadia-pharmaceuticals
|
Aug 23rd, 2022 12:00AM
|
Open
|
ACADIA Pharmaceuticals
|
|
Healthcare
|
ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase IV development as a treatment for Parkinson's disease psychosis.
|
RRv1_5M_25M
|
San Diego, CA
|
|
|
|
3.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18.00
|
18.00
|
3.50
|
3.90
|
3.20
|
3.40
|
3.60
|
8.00
|
About a week
|
9.00
|
MEDIUM
|
8.00
|
FAVORABLE
|
|
|
|
Aug 23rd, 2022 10:07AM
|
Aug 23rd, 2022 10:07AM
|
ACADIA Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:acad
|
https://www.indeed.com/cmp/acadia-pharmaceuticals
|
Aug 21st, 2022 12:00AM
|
Open
|
ACADIA Pharmaceuticals
|
|
Healthcare
|
ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase IV development as a treatment for Parkinson's disease psychosis.
|
RRv1_5M_25M
|
San Diego, CA
|
|
|
|
3.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18.00
|
18.00
|
3.50
|
3.90
|
3.20
|
3.40
|
3.60
|
8.00
|
About a week
|
9.00
|
MEDIUM
|
8.00
|
FAVORABLE
|
|
|
|
Aug 21st, 2022 11:51AM
|
Aug 21st, 2022 11:51AM
|
ACADIA Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:acad
|
https://www.indeed.com/cmp/acadia-pharmaceuticals
|
Aug 20th, 2022 12:00AM
|
Open
|
ACADIA Pharmaceuticals
|
|
Healthcare
|
ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase IV development as a treatment for Parkinson's disease psychosis.
|
RRv1_5M_25M
|
San Diego, CA
|
|
|
|
3.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18.00
|
18.00
|
3.50
|
3.90
|
3.20
|
3.40
|
3.60
|
8.00
|
About a week
|
9.00
|
MEDIUM
|
8.00
|
FAVORABLE
|
|
|
|
Aug 20th, 2022 01:28PM
|
Aug 20th, 2022 01:28PM
|
ACADIA Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:acad
|
https://www.indeed.com/cmp/acadia-pharmaceuticals
|
Aug 19th, 2022 12:00AM
|
Open
|
ACADIA Pharmaceuticals
|
|
Healthcare
|
ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase IV development as a treatment for Parkinson's disease psychosis.
|
RRv1_5M_25M
|
San Diego, CA
|
|
|
|
3.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18.00
|
18.00
|
3.50
|
3.90
|
3.20
|
3.40
|
3.60
|
8.00
|
About a week
|
9.00
|
MEDIUM
|
8.00
|
FAVORABLE
|
|
|
|
Aug 19th, 2022 11:52AM
|
Aug 19th, 2022 11:52AM
|
ACADIA Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:acad
|
https://www.indeed.com/cmp/acadia-pharmaceuticals
|
Aug 18th, 2022 12:00AM
|
Open
|
ACADIA Pharmaceuticals
|
|
Healthcare
|
ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase IV development as a treatment for Parkinson's disease psychosis.
|
RRv1_5M_25M
|
San Diego, CA
|
|
|
|
3.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18.00
|
18.00
|
3.50
|
3.90
|
3.20
|
3.40
|
3.60
|
8.00
|
About a week
|
9.00
|
MEDIUM
|
8.00
|
FAVORABLE
|
|
|
|
Aug 18th, 2022 03:35AM
|
Aug 18th, 2022 03:35AM
|
ACADIA Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:acad
|
https://www.indeed.com/cmp/acadia-pharmaceuticals
|
Aug 17th, 2022 12:00AM
|
Open
|
ACADIA Pharmaceuticals
|
|
Healthcare
|
ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase IV development as a treatment for Parkinson's disease psychosis.
|
RRv1_5M_25M
|
San Diego, CA
|
|
|
|
3.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18.00
|
18.00
|
3.50
|
3.90
|
3.20
|
3.40
|
3.60
|
8.00
|
About a week
|
9.00
|
MEDIUM
|
8.00
|
FAVORABLE
|
|
|
|
Aug 17th, 2022 09:14AM
|
Aug 17th, 2022 09:14AM
|
ACADIA Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|